Mereo Biopharma is a Biotech company based in London, United Kingdom. It has raised $119M in total funding. Latest round: IPO.
Mereo Biopharma funding overview
Mereo Biopharma is a Biotech company based in London, United Kingdom. Mereo Biopharma has raised $119M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in January 2015. The round record for Mereo Biopharma runs through 2015; nothing later has been disclosed. Investors on record include blue chip institutional investors.
Mereo Biopharma at a glance
Total raised
$119M
Latest round
IPO
Latest round date
January 2015
Industry
Biotech
Headquarters
London, United Kingdom
Notable investors
blue chip institutional investors
Frequently asked about Mereo Biopharma funding
How much has Mereo Biopharma raised?
Mereo Biopharma has raised $119M in total disclosed funding across the rounds on record.
Who has invested in Mereo Biopharma?
blue chip institutional investors are named among the investors backing Mereo Biopharma.
What was the latest Mereo Biopharma funding round?
The most recent disclosed round is an IPO, announced in January 2015.
Where is Mereo Biopharma based?
Mereo Biopharma is based in London, United Kingdom.
What sector does Mereo Biopharma operate in?
Mereo Biopharma is tracked under Biotech from London, United Kingdom, with $119M in disclosed funding.
When did Mereo Biopharma last raise?
The last disclosed Mereo Biopharma round closed in January 2015 at IPO.
Every Mereo Biopharma figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in London at a similar stage.
